British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March ...

Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities is only natural. | With GSK kicking its R&D engine into high gear in ...

In an industry pining for investment activity, real estate investment trust Boston Properties (BXP) has agreed to sell a 45 percent interest in two life sciences developments valued at about $1.66 ...

BOSTON, Dec. 16, 2021 /PRNewswire/ -- Newmark announces the $1.2 billion recapitalization of 50 + 60 Binney Street, two state-of-the-art life scie ...